Control of vascular reactivity in pregnancy: the basis for therapeutic approaches to prevent pregnancy-induced hypertension.
The complete pathophysiology of pregnancy-induced hypertension may never be completely defined until the specific offending gene can be isolated. Until this has been accomplished, however, there seems to be hope that rational treatment regimens soon will be available to prevent or at least delay the onset of pregnancy-induced hypertension.
Magness
R R
RR
Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas 75235.
Gant
N F
NF
D000450:Aldosterone / Q000502:physiology; D000804:Angiotensin II / Q000097:blood / Q000502:physiology; D005260:Female; D006801:Humans; D006973:Hypertension / Q000209:etiology* / Q000517:prevention & control*; D008657:Metabolic Clearance Rate; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular; D012084:Renin-Angiotensin System; D014655:Vascular Resistance
D000804:Angiotensin II; D000450:Aldosterone